The Toronto-based startup is applying AI to ultrasound signals. It differentiates healthy tissue from diseased tissue by measuring its acoustic properties.
The six companies taking part in the contest November 16 will present technologies addressing chronic conditions such as kidney disease and Type 2 diabetes as well as improving patient engagement for underinsured and underserved patients.